Ulceration

Melanoma patients benefit from immunotherapy drug: Study

Sep 20, 2021

According to the results of an international, randomised phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.

Recent News

25 minutes ago

NRB reports decline in foreign currency exchange rates

10 hours ago

KMC fines UML Rs 100,000 for littering

13 hours ago

Indian Army Chief Dwivedi meets with PM Oli

14 hours ago

Speaker Ghimire calls on President Paudel

15 hours ago

PM Oli refutes any misunderstandings between UML and NC

Reception in honour of President Paudel in Berlin

Nepal defeated by Bangladesh

Landslide obstructs Muglin-Malekhu road section

Nepal's First Online News Portal

Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

Kathmandu, Nepal,

Newsroom
##

E-mail
nepalnewseditor@gmail.com

Social Media

Facebook

Instagram

Twitter

Youtube

Exploration

About Us

Privacy Policy

Archive